Hosted by:

Cambia Grove - Virtual

Date & time




Due to the current public health threat of COVID-19, Cambia Grove's coworking space in Seattle will be closed until further notice. Cambia Grove Roundtables will be taking place virtually. Please be on the lookout for details from

Q&A roundtable discussions are conducted by members of the community to provide opportunities for a small group discussion with subject matter experts.

There are 8 seats at the table for the 90-minute discussion.

A few days prior, we will send out "Confirmation Required" emails to registrants. You must email back to confirm your spot or we will have to release your ticket.


Join Tiffany Kuo to talk about how to define your customers, understand their unmet needs, and build a business model for medical devices, drugs, diagnostics, and digital health products. 

Health care is quite a complex sector with multiple customer groups to consider. After all, the payer, user, and ultimately the beneficiary of the product may not be the same stakeholders. However, the complexity of the sector allows for business models where some of these customers can also be partners. We will discuss methods to identify who your most important customer groups/segments are and how to build a business model that can address various customers' needs.


Tiffany focuses on defining product and commercialization strategies for biotech, medical devices, and digital health products. Currently, her focus is on commercializing diagnostic products for PATH, a global health organization. Prior to PATH, she was a manager at Deloitte Consulting's Life Sciences and Healthcare practice where she helped companies understand their customers, define and develop their product strategy, and prepare for launch (e.g., regulatory approval, salesforce, marketing messages).

Tiffany co-founded a personalized medicine start-up called Multiply Labs and was responsible for identifying target customers, defining product strategy and business model, determining marketing strategy, building quality systems, preparing for regulatory approval, and raising a seed round.